InsiderTrades

Form 4 for OSCR Oscar Health, Inc.

Accepted 2024-12-03 00:00:00 ET · period of report 2024-12-01 · accession 0001562180-24-008101 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-12-03 2024-12-01 OSCR Quane Alessandrea C. EVP, Chief Insurance Off M - OptEx — +50.0K 442.7K +13% —
DM 2024-12-03 2024-12-02 OSCR Quane Alessandrea C. EVP, Chief Insurance Off S - Sale+OE $18.08 -26.9K 416.2K -6% -$486.2K
DM 2024-12-03 2024-12-01 OSCR Quane Alessandrea C. EVP, Chief Insurance Off M - OptEx $0.00 -50.0K 77.9K -39% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-12-01 M A 7,015 — 399,622 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
2 Common Class A Common Stock 2024-12-01 M A 34,379 — 434,001 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
3 Common Class A Common Stock 2024-12-02 S D 484 $18.48 415,759 D — — (F2) The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.46 to $18.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
4 Common Class A Common Stock 2024-12-02 S D 26,411 $18.07 416,243 D — — (F2) The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.46 to $18.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
5 Common Class A Common Stock 2024-12-01 M A 8,653 — 442,654 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
6 Derivative Restricted Stock Units 2024-12-01 M D 7,015 $0.00 21,048 D — · — to — 7,015 Class A Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock. (F5) The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021.
7 Derivative Restricted Stock Units 2024-12-01 M D 34,379 $0.00 309,417 D — · — to — 34,379 Class A Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock. (F6) The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023.
8 Derivative Restricted Stock Units 2024-12-01 M D 8,653 $0.00 77,872 D — · — to — 8,653 Class A Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock. (F7) The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.